Quest diagnostics incorporated
DGX 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分低，若以價值投資為目標且有長期投資部位，需要嚴格執行自己的出場計畫來減持部位
DGX 近期報酬表現
-0.86%
Quest diagnostics incorporated
6.23%
同產業平均
1.02%
S&P500
與 DGX 同產業的標的表現
| 股票代碼 | 公司名稱 | 價值 | 趨勢 | 波段 | 籌碼 | 股利 | 加入追蹤 |
|---|---|---|---|---|---|---|---|
LH | Laboratory corporation of america holdings | 2 分 | 1 分 | 1 分 | 2 分 | 1 分 | |
HOLX | Hologic inc | 4 分 | 3 分 | 4 分 | 2 分 | 1 分 | |
ABT | Abbott laboratories | 4 分 | 3 分 | 2 分 | 3 分 | 5 分 | |
WAT | Waters corp | 4 分 | 3 分 | 1 分 | 3 分 | 1 分 | |
IDXX | Idexx laboratories incorporated | 4 分 | 1 分 | 4 分 | 2 分 | 1 分 |
- LH Laboratory corporation of america holdings價值 2 分趨勢 1 分波段 1 分籌碼 2 分股利 1 分查看更多
DGX 公司資訊
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It provides diagnostic information services for infectious diseases, such as tuberculosis (e.g., T.SPOT.TB and Quantiferon offerings) and tick-borne disease (e.g., Accutix offering). Its comprehensive offerings in drug monitoring and toxicology, in neurology diagnostics, in advanced cardiovascular diagnostic information services (e.g. CARDIO IQ and Cleveland HeartLab offerings through its Cardiometabolic Center of Excellence), and in cancer diagnostics. Its Diagnostic Solutions business consists of its risk assessment services and healthcare information technology businesses. Its risk assessment service, ExamOne, is a provider of risk assessment services for the life insurance industry in North America.